Patients in the US receive record Botox injections in 2024 as use rises among the young
Updated
Updated · The Cut · Apr 24
Patients in the US receive record Botox injections in 2024 as use rises among the young
13 articles · Updated · The Cut · Apr 24
Over 9 million doses of Botox and similar neuromodulators were administered in the US in 2024, with a 71% rise among patients in their 20s and a 75% increase among those 19 and younger.
The surge is driven by preventative marketing, with 'Baby Botox' promoted as routine beauty maintenance and younger patients seeking to delay visible aging. Allergan, Botox's manufacturer, is targeting this demographic through new campaigns.
This trend raises debates about feminism, societal pressures, and emotional impacts, as some women grapple with the psychological and ethical implications of early cosmetic intervention while others embrace transparency and normalization of such procedures.
Will cheaper Botox alternatives make preventative injections the new normal?
Are 'preventative' injections creating a new epidemic of body dysmorphia?
How is the weight-loss drug boom reshaping the $100 billion aesthetics industry?
With the FDA cracking down in 2026, are 'lunchtime' injections actually safe?
Is society trading authentic emotional expression for a wrinkle-free face?
Fillers can last a decade, not 18 months. What are the hidden long-term risks?